CLINICAL_TRIALS
trial_result
· 2021-03-03
Clinical Trial Update: A Pilot Study of RNS60 in Amyotrophic Lateral Sclerosis (ALS) [Phase 1]
Summary
A Phase 1 pilot study of RNS60 in amyotrophic lateral sclerosis (ALS) has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sabrina Paganoni, M.D. | Conditions: ALS | Phase 1 | Status: COMPLETED | Results posted: 2021-03-03